{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:25:59Z","timestamp":1791149159310,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":843,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Innovative Medizinische Forschung (IMF) Foundation","award":["119827"],"award-info":[{"award-number":["119827"]}]},{"name":"The Netherlands Heart Foundation","award":["2006B107"],"award-info":[{"award-number":["2006B107"]}]},{"name":"The Netherlands Heart Foundation","award":["2007T056"],"award-info":[{"award-number":["2007T056"]}]},{"name":"Netherlands Organization for Scientific Research","award":["917-56-358"],"award-info":[{"award-number":["917-56-358"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.atherosclerosis.2010.12.026","type":"journal-article","created":{"date-parts":[[2011,1,20]],"date-time":"2011-01-20T09:30:55Z","timestamp":1295515855000},"page":"374-382","source":"Crossref","is-referenced-by-count":56,"title":["Native high-density lipoproteins inhibit platelet activation via scavenger receptor BI"],"prefix":"10.1016","volume":"215","author":[{"given":"Martin F.","family":"Brodde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne J.A.","family":"Korporaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazyna","family":"Herminghaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Fobker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo J.C.","family":"Van Berkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe J.F.","family":"Tietge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horst","family":"Robenek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda","family":"Van Eck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate E.","family":"Kehrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy-Roch","family":"Nofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0005","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/01.RES.0000160077.17427.57","article-title":"Platelets and chemokines in atherosclerosis: partners in crime","volume":"96","author":"Weber","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0010","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/MOL.0b013e3282ef7c1e","article-title":"Molecular pathways used by platelets to initiate and accelerate atherogenesis","volume":"18","author":"Lindemann","year":"2007","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/cvr\/cvn015","article-title":"Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis","volume":"78","author":"Siegel-Axel","year":"2008","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2010.12.026_bib0020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/01.CIR.93.2.229","article-title":"Platelet function in acute myocardial infarction treated with direct angioplasty","volume":"93","author":"Gawaz","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0025","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1161\/01.CIR.94.6.1239","article-title":"Increased neutrophil-platelet adhesion in patients with unstable angina","volume":"94","author":"Ott","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0030","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1172\/JCI108872","article-title":"The effect of thrombocytopenia on experimental atherosclerotic lesion formation in rabbits","volume":"60","author":"Friedman","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0035","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000093220","article-title":"Platelet activation by low density lipoproteins and high density lipoproteins","volume":"35","author":"Korporaal","year":"2006","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0040","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000093225","volume":"35","author":"Koller","year":"2006","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/CIRCULATIONAHA.107.709204","article-title":"Cardiovascular risk factors and venous thromboembolism: a meta-analysis","volume":"117","author":"Ageno","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0050","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0002-9149(99)00489-0","article-title":"Evidence that high-density lipoprotein cholesterol is an independent predictor of acute platelet-dependent thrombus formation","volume":"84","author":"Naqvi","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0055","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/01.ATV.18.6.861","article-title":"HDL3-mediated inhibition of thrombin-induced platelet aggregation and fibrinogen binding occurs via decreased production of phosphoinositide-derived second messengers 1,2-diacylglycerol and inositol 1,4,5-tris-phosphate","volume":"18","author":"Nofer","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0060","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1055\/s-0038-1650335","article-title":"High density lipoproteins enhance the Na+\/H+ antiport in human platelets","volume":"75","author":"Nofer","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0065","doi-asserted-by":"crossref","first-page":"12610","DOI":"10.1073\/pnas.94.23.12610","article-title":"A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism","volume":"94","author":"Rigotti","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0070","doi-asserted-by":"crossref","first-page":"19055","DOI":"10.1074\/jbc.274.27.19055","article-title":"A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism","volume":"274","author":"Febbraio","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0075","first-page":"1345","article-title":"The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum","volume":"3","author":"Havel","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0080","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1093\/clinchem\/33.12.2195","article-title":"Flow-cytometric determination of high-density-lipoprotein binding sites on human leukocytes","volume":"33","author":"Schmitz","year":"1987","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0085","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1016\/S0021-9258(18)34645-3","article-title":"Selective diminution of the binding of mannose by murine macrophages in the late stages of activation","volume":"257","author":"Imber","year":"1982","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0090","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/o59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can J Biochem Physiol"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0378-4347(97)00385-X","article-title":"Improved high-performance liquid chromatographic method for the separation and quantification of lipid classes: application to fish lipids","volume":"703","author":"Silversand","year":"1997","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0100","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2141.1996.445980.x","article-title":"Optimally functional fluorescein isothiocyanate (FITC)-labelled fibrinogen for quantitative studies of binding to activated platelets and platelet aggregation","volume":"93","author":"Xia","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0105","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.4049\/jimmunol.144.6.2334","article-title":"An indirect pathway of receptor-mediated 1,2-diacylglycerol formation in mast cells I. IgE receptor-mediated activation of phospholipase D","volume":"144","author":"Gruchalla","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0110","doi-asserted-by":"crossref","first-page":"17551","DOI":"10.1074\/jbc.272.28.17551","article-title":"Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes","volume":"272","author":"Murao","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0115","doi-asserted-by":"crossref","first-page":"16221","DOI":"10.1074\/jbc.270.27.16221","article-title":"The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids","volume":"270","author":"Rigotti","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0120","doi-asserted-by":"crossref","first-page":"21003","DOI":"10.1016\/S0021-9258(17)31921-X","article-title":"Expression cloning of SR-BI, a CD36-related class B scavenger receptor","volume":"269","author":"Acton","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0125","doi-asserted-by":"crossref","first-page":"12412","DOI":"10.1016\/S0021-9258(18)63874-8","article-title":"Purification and identification of the lipoprotein-binding proteins from human blood platelet membrane","volume":"264","author":"Koller","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0021-9150(00)00442-1","article-title":"Platelet HDL(3) binding sites are not related to integrin alpha(IIb) beta(3) (GPIIb-IIIa)","volume":"154","author":"Pedre\u00f1o","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0135","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0022-2275(20)38312-7","article-title":"Binding of apoE-rich high density lipoprotein particles by saturable sites on human blood platelets inhibits agonist-induced platelet aggregation","volume":"30","author":"Desai","year":"1989","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0140","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0022-2275(20)34910-5","article-title":"Identification and characterization of LRP8 (apoER2) in human blood platelets","volume":"40","author":"Riddell","year":"1999","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0145","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0006-291X(91)92084-W","article-title":"Inhibition of platelet function by high-density lipoprotein from a patient with apolipoprotein E deficiency","volume":"181","author":"Higashihara","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0150","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/01.ATV.0000067429.46333.7B","article-title":"Expression of human scavenger receptor B1 on and in human platelets","volume":"23","author":"Imachi","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0155","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1182\/blood-2007-08-107813","article-title":"Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI","volume":"111","author":"Valiyaveettil","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0160","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.febslet.2008.02.001","article-title":"Oxidation by hypochlorite converts protective HDL into a potent platelet agonist","volume":"582","author":"Assinger","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0165","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/nm1626","article-title":"Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype","volume":"13","author":"Podrez","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0021-9150(89)90094-4","article-title":"Platelet activation by oxidatively modified low density lipoproteins","volume":"76","author":"Ardlie","year":"1989","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0175","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1006\/bbrc.1996.0765","article-title":"Native lipoproteins inhibit platelet activation induced by oxidized lipoproteins","volume":"222","author":"Takahashi","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2010.12.026_bib0180","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1161\/CIRCULATIONAHA.109.870709","article-title":"Reconstituted high-density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol efflux","volume":"120","author":"Calkin","year":"2009","journal-title":"Circulation"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011000438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915011000438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T22:47:08Z","timestamp":1685918828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915011000438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0021915011000438"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2010.12.026","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}